956958-53-5

956958-53-5 structure
956958-53-5 structure
  • Name: XL147
  • Chemical Name: N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide
  • CAS Number: 956958-53-5
  • Molecular Formula: C21H16N6O2S2
  • Molecular Weight: 448.52100
  • Catalog: Biochemical Inhibitor PI3K/Akt/mTOR inhibitor (PI3K/Akt/mTOR) PI3K inhibitor
  • Create Date: 2018-11-30 18:43:47
  • Modify Date: 2026-07-13 09:54:32
  • Pilaralisib analogue (XL147 analogue) is a representative and selective PI3Kα inhibitor extracted from patent WO2012006552A1, Compound 147 in Table 1.

Name N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide
Synonyms Pilalisib analog (XL147 analog, S245408 analog)
PI3K inhibitor X
SAR245408
XL147 analog XL-147
S245408
XL147;XL-147;S245408
S245408 (XL-147)
N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide XL
N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide
Benzenesulfonamide, N-[3-(2,1,3-benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methyl
XL147 analogue(PI3K inhibitor X)
XL-147 derivative 2
XL 147
XL-147(S245408)
PI3K inhibitorX
XL147 analogue ,S1118
N-[3-(Benzo[c][1,2,5]thiadiazol-5-ylaMino)quinoxalin-2-yl]-4-MethylbenzenesulfonaMide
XL147 //BP
9S)-Cinchonine
N-(3-(Benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenes ulfonamide
XL-147
XL147 ANALOG
XL147 analogue
XL147;XL
XL147, >=
Pilalisib analogue, 10 mM in DMSO
Description Pilaralisib analogue (XL147 analogue) is a representative and selective PI3Kα inhibitor extracted from patent WO2012006552A1, Compound 147 in Table 1.
Related Catalog
Target

PI3K-alpha

References

[1]. Carlos L. Arteaga, et al. Combinations of kinase inhibitors for the treatment of cancer. WO 2012006552 A1.

Density 1.538
Molecular Formula C21H16N6O2S2
Molecular Weight 448.52100
Exact Mass 448.07800
PSA 149.61000
LogP 5.06300
Storage condition -20℃
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.